MedPath

A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

Phase 2
Completed
Conditions
Open-angle Glaucoma
Ocular Hypertension
Registration Number
NCT00326092
Lead Sponsor
Alcon Research
Brief Summary

The purpose of this study is to assess the comfort of a glaucoma therapy in patients with open-angle glaucoma or ocular hypertension

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
88
Inclusion Criteria
  • Adults of either sex and any race diagnosed with open-angle glaucoma (with or without pseudoexfoliation or pigment dispersion component)
Exclusion Criteria
  • Under 18

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Ocular discomfort
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Fort Worth and Other Sites

🇺🇸

Fort Worth, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath